cysteine has been researched along with monomethyl auristatin e in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alley, SC; Andreyka, J; Carter, P; Francisco, JA; Hamblett, KJ; Kim, K; McDonagh, CF; Stone, I; Turcott, E; Webster, JB; Westendorf, L | 1 |
Bhakta, S; Chen, Y; Clark, S; Dennis, MS; Duenas, E; Flagella, K; Gorrell, J; Junutula, JR; Katta, V; Kim, A; Lee Wong, W; Lee, CC; Leipold, DD; Lowman, HB; Lu, Y; Mallet, W; McDorman, K; Meng, YG; Ng, C; Polakis, P; Raab, H; Ross, S; Scheller, RH; Simpson, M; Sliwkowski, MX; Spencer, SD; Tsai, SP; Vandlen, R; Venook, R; Weir, S; Yang, J | 1 |
McFee, WA; Salas-Solano, O; Valliere-Douglass, JF | 1 |
Liu-Shin, L; Ratnaswamy, G; Wiggins, B; Yamaguchi, H | 1 |
Bezabeh, B; Christie, RJ; Dimasi, N; Fleming, R; Gao, C; Harper, J; Joseph, A; Mao, S; Wang, Q; Woods, R; Wu, H; Xu, ZQ | 1 |
Krzyscik, MA; Lobocki, M; Otlewski, J; Sokolowska-Wedzina, A; Szlachcic, A; Zakrzewska, M | 1 |
Bhakta, J; Bhakta, S; Bos, AB; Cook, R; Dela Cruz-Chuh, J; Erickson, H; Farahi, F; Fourie-O'Donohue, A; Junutula, JR; Kozak, KR; Liu, Y; Ng, C; Ohri, R; Pillow, TH; Polakis, P; Raab, H; Tsai, SP; Vandlen, R; Wei, B; Wong, AW | 1 |
7 other study(ies) available for cysteine and monomethyl auristatin e
Article | Year |
---|---|
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Base Sequence; Binding Sites; Cysteine; Disulfides; Immunoconjugates; Ki-1 Antigen; Ligands; Maximum Tolerated Dose; Mice; Oligopeptides; Protein Engineering; Serine; Solvents; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antineoplastic Agents; Binding Sites; CA-125 Antigen; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Cytotoxins; Female; Humans; Immunotoxins; Macaca fascicularis; Membrane Proteins; Mice; Mutagenesis, Site-Directed; Oligopeptides; Ovarian Neoplasms; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 2008 |
Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.
Topics: Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Cysteine; Immunoconjugates; Immunoglobulin G; Mass Spectrometry; Oligopeptides; Recombinant Proteins | 2012 |
Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal, Humanized; Brentuximab Vedotin; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Cross-Linking Reagents; Cysteine; Drug Stability; Electrophoresis, Capillary; Hydrophobic and Hydrophilic Interactions; Immunoconjugates; Immunoglobulin G; Immunoglobulin Heavy Chains; Immunoglobulin Light Chains; Mass Spectrometry; Maytansine; Oligopeptides; Peptide Mapping; Protein Stability; Technology, Pharmaceutical; Temperature; Trastuzumab | 2015 |
Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Chemistry, Pharmaceutical; Cross-Linking Reagents; Cysteine; Drug Stability; Hydrolysis; Immunoconjugates; Kinetics; Maleimides; Models, Chemical; Models, Molecular; Oligopeptides; Protein Conformation; Protein Stability; Sulfhydryl Compounds | 2015 |
High-Yield Site-Specific Conjugation of Fibroblast Growth Factor 1 with Monomethylauristatin E via Cysteine Flanked by Basic Residues.
Topics: Amino Acid Motifs; Animals; Antineoplastic Agents; Binding Sites; Cell Death; Cell Line, Tumor; Cysteine; Drug Delivery Systems; Endocytosis; Fibroblast Growth Factor 1; Humans; Oligopeptides; Receptor, Fibroblast Growth Factor, Type 1 | 2017 |
High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers.
Topics: Animals; Antineoplastic Agents, Immunological; Cysteine; Disulfides; Drug Stability; High-Throughput Screening Assays; Humans; Immunoconjugates; Maleimides; Models, Molecular; Mutagenesis, Site-Directed; Oligopeptides; Protein Aggregates; Protein Stability; Rats; Trastuzumab | 2018 |